Close Menu
The Startup StoryThe Startup Story
  • Business
  • Lifestyle
  • National
  • Education
  • Health
  • Technology
  • World

Subscribe to Updates

Get the latest creative news from FooBar about art, design and business.

What's Hot

Megamont Limited Reports Q2 FY27 Revenue of Rs. 591.06 Crores, Up 169.63% QoQ; PAT Up 151.11% QoQ

November 17, 2026

Prateek Group: A Legacy of Trust, A New Vision of Fine Living

November 17, 2026

V.L. Infraprojects Reports H1 FY27 Total Income of Rs 71.79 Crore, up 14.14% YoY

November 17, 2026
Facebook X (Twitter) Instagram
Trending
  • Megamont Limited Reports Q2 FY27 Revenue of Rs. 591.06 Crores, Up 169.63% QoQ; PAT Up 151.11% QoQ
  • Prateek Group: A Legacy of Trust, A New Vision of Fine Living
  • V.L. Infraprojects Reports H1 FY27 Total Income of Rs 71.79 Crore, up 14.14% YoY
  • Ye Mahaveer Ka Panth Hai, Har Prani Me Sant Hai’ – Mahavir Nirvana Katha resonates at Bharat Mandapam
  • Unihealth Hospitals Limited Reports H1 FY27 Revenue of Rs 76.45 Crore; Positive Operating Cash Flow of Rs 23.83 Crore Amidst Significant Expansion Investments
  • Chhattisgarh CM Inaugurates PanIIT Alumni India’s Nursing Skill College Initiative in Jashpur
  • 8th International HKL Conference Begins at Gurdwara Bulandpuri Sahib; Flags of 116 Nations Hoisted to Promote Global Unity
  • Cash Ur Drive Marketing Reports Strong H1 FY27 Performance: EBITDA Rising 13% and Net Profit Growing 8% YoY
The Startup StoryThe Startup Story
  • Business
  • Lifestyle
  • National
  • Education
  • Health
  • Technology
  • World
The Startup StoryThe Startup Story
Home»Business»Sankalp Life Care, Vaishali Pharma sign unique partnership agreement, a first in nutraceuticals market
Business

Sankalp Life Care, Vaishali Pharma sign unique partnership agreement, a first in nutraceuticals market

By April 20, 2022No Comments
Facebook Twitter Pinterest LinkedIn WhatsApp Reddit Tumblr Email
Share
Facebook Twitter LinkedIn Pinterest Email
Read Time:2 Minute, 8 Second

As per an agreement signed between the two companies, Vaishali Pharma will take over the domestic and international marketing operations of Sankalp Life Care

Ahmedabad (Gujarat) [India], April 20: Ahmedabad-based Sankalp Life Care, a leading manufacturer of nutraceuticals, and Mumbai-headquartered Vaishali Pharma, a leading manufacturer and exporter of pharma formulations, have come together to form a unique partnership that will help both companies grow faster.

As per the agreement between the two companies, NSE-listed Vaishali Pharma will take over the entire domestic and international marketing of Sankalp Life Care’s portfolio of nutraceutical products.

“This is a perfect partnership. Sankalp Life Care’s core strength is in manufacturing the best quality nutraceutical products, and Vaishali Pharma has a wide global presence in the Indian and multiple markets and specialises in marketing. The partnership will allow us to leverage Vaishali Pharma’s marketing reach and focus on our expertise. It is a win-win for both companies and we look forward to growing together and offering the highest-quality nutraceutical products to customers in India and around the world,” said Robin Goenka, Managing Director, Sankalp Life Care.

“This agreement between Vaishali Pharma and Sankalp Life Care is the first-of-its-kind in the Indian pharma industry. Vaishali Pharma will handle the complete domestic and international marketing operations of Sankalp Life Care, and make Sankalp Life Care’s 100+ innovative products available in more than 40 countries. The unique agreement builds on the strengths of the two companies and will be mutually beneficial,” said Atul Vasani, Managing Director, Vaishali Pharma.

Sankalp Life Care is a leading nutraceuticals company and has set up the 5th largest nutraceuticals facility in the country at Bavla, Ahmedabad. A range of tablets, capsules, powders, sachets, gummies, liquid and effervescent tablets, among other products are made at the zero-discharge facility, which is fully operational now, and has been designed as per standards defined by World Health Organisation. It is also designed as per USFDA standards and the company has already made an application for USFDA approval for the facility.

Vaishali Pharma, which manufactures and exports pharma formulations in a wide spectrum of dosage forms & therapeutic segments, Active Pharmaceutical Ingredients (APIs), surgical products, nutraceutical, and oncology products, is one of the fastest-growing and most versatile companies in the industry. It has a strong presence in both the domestic and export markets and is currently a supplier to all leading Indian and multinational pharmaceutical companies. The company has been catering to semi-regulated and non-regulated markets across the globe.

About Post Author


RNT Reporter


dhaval.rntoday@gmail.com

https://republicnewstoday.com

The post Sankalp Life Care, Vaishali Pharma sign unique partnership agreement, a first in nutraceuticals market appeared first on Republic News Today.

Business
Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email

Related Posts

Prateek Group: A Legacy of Trust, A New Vision of Fine Living

November 17, 2026

V.L. Infraprojects Reports H1 FY27 Total Income of Rs 71.79 Crore, up 14.14% YoY

November 17, 2026

Batman x Samsonite: Iconic DC Super Hero, Reimagined Through the Lens of Modern Travel

November 16, 2026

Comments are closed.

Top Posts

Megamont Limited Reports Q2 FY27 Revenue of Rs. 591.06 Crores, Up 169.63% QoQ; PAT Up 151.11% QoQ

November 17, 2026

Can we guess, how much she is happy?

February 22, 2020

When sunrise and the day begins.

February 22, 2020

Make your own inhouse library and learn

February 22, 2020
Don't Miss
Finance

Megamont Limited Reports Q2 FY27 Revenue of Rs. 591.06 Crores, Up 169.63% QoQ; PAT Up 151.11% QoQ

By Arjun SinghNovember 17, 2026

Mumbai (Maharashtra) [India], November 16: Megamont Limited (BSE: 523888) has announced its unaudited consolidated financial…

Prateek Group: A Legacy of Trust, A New Vision of Fine Living

November 17, 2026

V.L. Infraprojects Reports H1 FY27 Total Income of Rs 71.79 Crore, up 14.14% YoY

November 17, 2026

Ye Mahaveer Ka Panth Hai, Har Prani Me Sant Hai’ – Mahavir Nirvana Katha resonates at Bharat Mandapam

November 16, 2026
Most Popular

Megamont Limited Reports Q2 FY27 Revenue of Rs. 591.06 Crores, Up 169.63% QoQ; PAT Up 151.11% QoQ

November 17, 2026

Can we guess, how much she is happy?

February 22, 2020

When sunrise and the day begins.

February 22, 2020
Categories
  • Business
  • Business News
  • Education
  • Entertainment
  • Finance
  • Health
  • Lifestyle
  • National
  • Press Release
  • Sports
  • Technology
  • Uncategorized
  • World
Our Picks

Megamont Limited Reports Q2 FY27 Revenue of Rs. 591.06 Crores, Up 169.63% QoQ; PAT Up 151.11% QoQ

November 17, 2026

Prateek Group: A Legacy of Trust, A New Vision of Fine Living

November 17, 2026

V.L. Infraprojects Reports H1 FY27 Total Income of Rs 71.79 Crore, up 14.14% YoY

November 17, 2026

Type above and press Enter to search. Press Esc to cancel.